Infectious Diseases
Global

Infectious Diseases Experts

Reza Halse

Director
Infectious diseases
Visterra
United States of America

Biography

Dr. Halse serves as head of the European Innovation Hub at Merck & Co., Inc., Investment Arm and as Associate Vice President and Partner of MRL Ventures, where he is responsible for leading business development and licensing activities, with a focus on early-stage therapeutics. Previously, Dr. Halse was a partner with the corporate venture capital arm of Partners HealthCare, a large academic medical center and Harvard Medical School affiliate, based in Boston, US. In this role, he led investments and had Board responsibility for a number of therapeutics and technology platform companies, spanning infectious disease, oncology, neurology, inflammation and genome editing. Prior to this, he was a founding member of a US-based product development company, BioMed Valley Discoveries, that in-licensed and advanced a number of oncology assets into clinical trials. He also had management roles of increasing responsibility at Novartis, based in the US, initially in the diabetes and metabolism group, and then in an internal incubator with a mandate to develop programs outside the core disease areas. Earlier in his career, he led research at Xcellsyz Ltd, a venture-backed start up in the UK. Dr. Halse holds a B.Sc. and Ph.D. from Newcastle University, UK.

Research Interest

Previously, Dr. Halse was a partner with the corporate venture capital arm of Partners HealthCare, a large academic medical center and Harvard Medical School affiliate, based in Boston, US. In this role, he led investments and had Board responsibility for a number of therapeutics and technology platform companies, spanning infectious disease, oncology, neurology, inflammation and genome editing. Prior to this, he was a founding member of a US-based product development company, BioMed Valley Discoveries, that in-licensed and advanced a number of oncology assets into clinical trials. He also had management roles of increasing responsibility at Novartis, based in the US, initially in the diabetes and metabolism group, and then in an internal incubator with a mandate to develop programs outside the core disease areas. Earlier in his career, he led research at Xcellsyz Ltd, a venture-backed start up in the UK. Dr. Halse holds a B.Sc. and Ph.D. from Newcastle University, UK.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Relevant Topics